These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18430978)

  • 1. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline.
    Oztürk C; Ozge A; Yalin OO; Yilmaz IA; Delialioglu N; Yildiz C; Tesdelen B; Kudiaki C
    Behav Neurol; 2007; 18(4):207-15. PubMed ID: 18430978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance.
    Wilson JS; Mruthinti S; Buccafusco JJ; Schade RF; Mitchell MB; Harrell DU; Gulati NK; Miller LS
    J Gerontol A Biol Sci Med Sci; 2009 Feb; 64(2):264-71. PubMed ID: 19196906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy.
    Schmitz M; Hermann P; Oikonomou P; Stoeck K; Ebert E; Poliakova T; Schmidt C; Llorens F; Zafar S; Zerr I
    Neurobiol Aging; 2015 Sep; 36(9):2597-606. PubMed ID: 26170132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
    Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
    J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
    Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
    J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease.
    Sobów T; Flirski M; Kłoszewska I; Liberski PP
    Acta Neurobiol Exp (Wars); 2005; 65(2):117-24. PubMed ID: 15960295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of inflammatory cytokines in mild cognitive impairment.
    Magaki S; Mueller C; Dickson C; Kirsch W
    Exp Gerontol; 2007 Mar; 42(3):233-40. PubMed ID: 17085001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
    Iulita MF; Ganesh A; Pentz R; Flores Aguilar L; Gubert P; Ducatenzeiler A; Christie S; Wilcock GK; Cuello AC
    J Alzheimers Dis; 2019; 67(1):327-341. PubMed ID: 30636741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.
    Neergaard JS; Dragsbæk K; Christiansen C; Karsdal MA; Brix S; Henriksen K
    PLoS One; 2018; 13(4):e0194802. PubMed ID: 29641555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias.
    Chen A; Oakley AE; Monteiro M; Tuomela K; Allan LM; Mukaetova-Ladinska EB; O'Brien JT; Kalaria RN
    Neurobiol Aging; 2016 Feb; 38():56-67. PubMed ID: 26827643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer's disease.
    Zhang J; Jia J; Qin W; Wang S
    Neurosci Lett; 2013 Apr; 541():99-104. PubMed ID: 23500026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
    Jongbloed W; Bruggink KA; Kester MI; Visser PJ; Scheltens P; Blankenstein MA; Verbeek MM; Teunissen CE; Veerhuis R
    J Alzheimers Dis; 2015; 45(1):35-43. PubMed ID: 25547634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.